Literature DB >> 23416655

Characterization of Streptococcus pneumoniae isolates from India with special reference to their sequence types.

Malini Shariff1, Jyoti Choudhary, Shazia Zahoor, Monorama Deb.   

Abstract

INTRODUCTION: Streptococcus pneumoniae is a major cause of mortality and morbidity in young children and the elderly. In the present study we evaluated antimicrobial susceptibilities, serotypes, and sequence types of pneumococcal isolates recovered in New Delhi, India.
METHODOLOGY: A total of 126 clinical isolates of Streptococcus pneumoniae were investigated. They were subjected to disk diffusion susceptibility testing, broth microdilution testing, serotyping and multilocus sequence typing.
RESULTS: Broth microdilution assay showed that 5%, 20% and 23% of the isolates exhibited resistance to penicillin, erythromycin and ciprofloxacin, respectively. Serotypes19, 1 and 6 were more frequently isolated. Thirty per cent of the strains were comprised of serotypes 1, 3, 5, 19A and 7F, which are not included in the seven-valent vaccine. Fifty-nine isolates were typed using multilocus sequence typing. Thirty new sequence types were encountered in this study. Only one clonal complex with 4 isolates was seen; 11 clonal complexes and 96 sequence types (STs) were observed among 115 Indian isolates. Only 18 of the 96 STs were found globally, of which only 4 STs were found in many countries with larger numbers.
CONCLUSIONS: This study identifies the non-vaccine serotypes of Streptococcus pneumoniae circulating in India. It is important that an appropriate vaccine which covers all serotypes is used in the region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416655     DOI: 10.3855/jidc.2553

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  5 in total

Review 1.  Pneumococcal Vaccines - How Many Serotypes are Enough?

Authors:  Aaradhana Singh; A K Dutta
Journal:  Indian J Pediatr       Date:  2017-09-09       Impact factor: 1.967

2.  Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial.

Authors:  Bhagirath B Solanki; Christine Juergens; Manojkumar B Chopada; Pravin Supe; Vani Sundaraiyer; Natacha Le Dren-Narayanin; Mark W Cutler; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

Review 3.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08

4.  Conjugate pneumococcal vaccines: need and choice in India.

Authors:  Akash Malik; Dk Taneja
Journal:  Indian J Community Med       Date:  2013-10

5.  Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia.

Authors:  Wondemagegn Mulu; Endalew Yizengaw; Megbaru Alemu; Daniel Mekonnen; Derese Hailu; Kassaw Ketemaw; Bayeh Abera; Mulugeta Kibret
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.